Skip to content

A comparative study of the safety and efficacy of remimazolam versus propofol for cervical conization

A comparative study of the safety and efficacy of remimazolam versus propofol for cervical conization

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065519
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-14
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

R:Intraoperative sedation with remimazolam
P:Intraoperative sedation with propofol

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent conical hysterectomy in elective surgery; 2. Patients with ASA grade I-II; 3. Age 18-65 years; 4. BMI 18.5~30

Exclusion criteria

Exclusion criteria: 1. Patients with long-term benzodiazepine use; 2. Patients with severe hypertension, coronary artery disease, and abnormal electrocardiogram; 3. Psychiatric patients; 4. Hypoproteinemia; 5. Abnormal liver and kidney function; 6. Patients with asthma and COPD

Design outcomes

Primary

MeasureTime frame
Whether the patient present with SpO2 <95;

Secondary

MeasureTime frame
Whether injection pain occurs;Time from awake to PSi <50;Arterial blood pressure and heart rate before and after induction and at the end of the procedure;Respiratory rate and end-expiratory carbon dioxide concentration before and after induction and at the end of the procedure;Is the patient with glossoptosis after induction;Number of body movements during surgery;Number and dose of vasoactive drugs;The time between stopping the pump and opening the eyes to listen to the commands;Is there nausea and vomiting 0.5h after surgery;Whether intraoperative awareness occurs;

Countries

China

Contacts

Public ContactTao Yan

Cancer Hospital, Chinese Academy of Medical Sciences

blizzardyt@163.com+86 13522553375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026